TY - JOUR
T1 - Rapid and Label-Free Histopathology of Oral Lesions Using Deep Learning Applied to Optical and Infrared Spectroscopic Imaging Data
AU - Confer, Matthew P.
AU - Falahkheirkhah, Kianoush
AU - Surendran, Subin
AU - Sunny, Sumsum P.
AU - Yeh, Kevin
AU - Liu, Yen-Ting
AU - Sharma, Ishaan
AU - Orr, Andres C.
AU - Lebovic, Isabella
AU - Magner, William J.
AU - Sigurdson, Sandra Lynn
AU - Aguirre, Alfredo
AU - Markiewicz, Michael R.
AU - Suresh, Amritha
AU - Hicks, Wesley L.
AU - Birur, Praveen
AU - Kuriakose, Moni Abraham
AU - Bhargava, Rohit
N1 - Research reported in this publication was supported by the National Institutes of Health under award numbers R01EB009745 and P41EB031772. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The samples used in this study were provided by the Roswell Park Comprehensive Cancer Center’s Pathology Network Resource supported by National Cancer Institute (NCI) grant P30CA016056.
PY - 2024/3
Y1 - 2024/3
N2 - Oral potentially malignant disorders (OPMDs) are precursors to over 80% of oral cancers. Hematoxylin and eosin (H&E) staining, followed by pathologist interpretation of tissue and cellular morphology, is the current gold standard for diagnosis. However, this method is qualitative, can result in errors during the multi-step diagnostic process, and results may have significant inter-observer variability. Chemical imaging (CI) offers a promising alternative, wherein label-free imaging is used to record both the morphology and the composition of tissue and artificial intelligence (AI) is used to objectively assign histologic information. Here, we employ quantum cascade laser (QCL)-based discrete frequency infrared (DFIR) chemical imaging to record data from oral tissues. In this proof-of-concept study, we focused on achieving tissue segmentation into three classes (connective tissue, dysplastic epithelium, and normal epithelium) using a convolutional neural network (CNN) applied to three bands of label-free DFIR data with paired darkfield visible imaging. Using pathologist-annotated H&E images as the ground truth, we demonstrate results that are 94.5% accurate with the ground truth using combined information from IR and darkfield microscopy in a deep learning framework. This chemical-imaging-based workflow for OPMD classification has the potential to enhance the efficiency and accuracy of clinical oral precancer diagnosis.
AB - Oral potentially malignant disorders (OPMDs) are precursors to over 80% of oral cancers. Hematoxylin and eosin (H&E) staining, followed by pathologist interpretation of tissue and cellular morphology, is the current gold standard for diagnosis. However, this method is qualitative, can result in errors during the multi-step diagnostic process, and results may have significant inter-observer variability. Chemical imaging (CI) offers a promising alternative, wherein label-free imaging is used to record both the morphology and the composition of tissue and artificial intelligence (AI) is used to objectively assign histologic information. Here, we employ quantum cascade laser (QCL)-based discrete frequency infrared (DFIR) chemical imaging to record data from oral tissues. In this proof-of-concept study, we focused on achieving tissue segmentation into three classes (connective tissue, dysplastic epithelium, and normal epithelium) using a convolutional neural network (CNN) applied to three bands of label-free DFIR data with paired darkfield visible imaging. Using pathologist-annotated H&E images as the ground truth, we demonstrate results that are 94.5% accurate with the ground truth using combined information from IR and darkfield microscopy in a deep learning framework. This chemical-imaging-based workflow for OPMD classification has the potential to enhance the efficiency and accuracy of clinical oral precancer diagnosis.
KW - discrete frequency infrared microscopy
KW - deep learning
KW - multimodal imaging
KW - oral potentially malignant lesions
KW - precancerous condition
UR - http://www.scopus.com/inward/record.url?scp=85188931535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85188931535&partnerID=8YFLogxK
U2 - 10.3390/jpm14030304
DO - 10.3390/jpm14030304
M3 - Article
C2 - 38541046
SN - 2075-4426
VL - 14
JO - Journal of Personalized Medicine
JF - Journal of Personalized Medicine
IS - 3
M1 - 304
ER -